biologicals

简明释义

英[ˌbaɪəˈlɒdʒɪkəlz]美[ˌbaɪəˈlɑdʒɪkəlz]

n. 生物制剂

英英释义

单词用法

同义词

反义词

例句

1.Being able to identify potential responders or non-responders means that patients can be selected for therapies that could have side-effects and, if they are one of the new biologicals, are expensive.

能够识别可能有效或无效意味着，如果是一个新的昂贵的生物制品，可能有副作用，可以选择合适的病人治疗。

2.Being able to identify potential responders or non-responders means that patients can be selected for therapies that could have side-effects and, if they are one of the new biologicals, are expensive.

能够识别可能有效或无效意味着，如果是一个新的昂贵的生物制品，可能有副作用，可以选择合适的病人治疗。

3.The gold leaching biologicals were prepared from protein rich surplus stock of food industry after changing property through hydrolysis.

选用富含蛋白质的食品工业下脚料经水解改性以后，制备成生物浸金制剂。

4.Anti-infectious agents like quinolones, macrolides, TCM with anti-infectious effect and biologicals & biochemicals, vitamins had grown.

喹诺酮类、 大环内酯类、抗感染中成药类抗感染药物以及生物制品与生化药物、维生素类药物均有增长；

5.Rotarix is manufactured by GlaxoSmithKline Biologicals, Rixensart, Belgium.

Rotarix由比利时葛兰素史克生物制品公司生产制造。

6.The result show that zinc, copper, iron, chromium, mangan, nickel, cadmium, calcium content in 6 biologicals are the most rich in ant factor injection liquid.

结果表明，6种生物制剂中锌、铜、铁、铬、锰、镍、镉、钙均以蚂蚁因子含量最高，钾含量则以转移因子、 胸腺肽较丰富；

7.increased production of safe and efficacious rabies biologicals, which are in critical short supply globally, particularly rabies immunoglobulin;

扩大全球紧缺的安全有效狂犬病生物制品（尤其是抗狂犬病免疫球蛋白）的生产；

8.Another trend is that there are more regional deals being done, and more deals done on biologicals.

另一个趋势是区域性和生物相关性的交易在增多。

9.Many biologicals (生物制剂) require careful storage and handling to maintain their efficacy.

许多生物制剂需要谨慎存储和处理以维持其有效性。

10.Researchers are exploring the use of biologicals (生物制剂) to enhance the immune response in patients.

研究人员正在探索使用生物制剂来增强患者的免疫反应。

11.The introduction of biologicals (生物制剂) has revolutionized the treatment of autoimmune diseases.

生物制剂的引入彻底改变了自身免疫性疾病的治疗。

12.Patients often prefer biologicals (生物制剂) over traditional medications due to their targeted action.

患者通常更喜欢生物制剂而不是传统药物，因为它们具有针对性作用。

13.The pharmaceutical company specializes in developing new biologicals (生物制剂) for treating chronic diseases.

这家制药公司专注于开发新的生物制剂用于治疗慢性疾病。

作文

In recent years, the field of medicine has witnessed remarkable advancements, particularly in the development of therapies known as biologicals. These are products derived from living organisms that are used in the diagnosis, prevention, and treatment of diseases. The significance of biologicals cannot be overstated, as they represent a shift from traditional synthetic medications to more targeted therapies that can be tailored to individual patients. This essay aims to explore the importance of biologicals, their applications, and the future of this innovative approach in healthcare.Firstly, one of the most notable advantages of biologicals is their ability to specifically target certain pathways in the body. Unlike conventional drugs that may affect multiple systems, biologicals are designed to interact with specific molecules involved in disease processes. For instance, monoclonal antibodies, a type of biological therapy, can be engineered to bind to particular proteins on cancer cells, thereby inhibiting their growth. This precision not only enhances the efficacy of treatments but also minimizes side effects, leading to better patient outcomes.Moreover, biologicals have revolutionized the treatment of chronic diseases such as rheumatoid arthritis, diabetes, and various forms of cancer. Patients who previously had limited options now benefit from these advanced therapies. For example, the introduction of biologicals for rheumatoid arthritis has transformed the management of this debilitating condition, allowing many individuals to lead more active and fulfilling lives. The success stories associated with biologicals highlight their potential to change the landscape of modern medicine.However, the development and production of biologicals come with their own set of challenges. The complexity of living organisms means that creating these therapies is often a lengthy and costly process. Additionally, the manufacturing of biologicals requires stringent quality control measures to ensure safety and efficacy. Despite these hurdles, the investment in research and development continues to grow, driven by the promise that biologicals hold for treating previously untreatable conditions.Looking ahead, the future of biologicals appears promising. Advances in biotechnology, including gene editing techniques like CRISPR, are paving the way for even more innovative therapies. These technologies could potentially allow for the creation of personalized biologicals that are tailored to the unique genetic makeup of individual patients. Such developments could revolutionize the treatment of genetic disorders and improve the overall effectiveness of therapies.In conclusion, biologicals represent a significant advancement in the field of medicine, offering targeted and effective treatment options for a variety of diseases. As research continues to evolve, the potential for biologicals to improve patient outcomes and transform healthcare is immense. The ongoing commitment to understanding and harnessing the power of living organisms will undoubtedly lead to new breakthroughs that enhance our ability to combat diseases and improve the quality of life for countless individuals. As we embrace this new era of medicine, the role of biologicals will continue to expand, shaping the future of healthcare for generations to come.

近年来，医学领域见证了显著的进步，特别是在被称为生物制剂的治疗方法的发展上。这些产品源自活生物体，用于疾病的诊断、预防和治疗。生物制剂的重要性不容小觑，因为它们代表了一种从传统合成药物到更具针对性的疗法的转变，这些疗法可以根据个体患者的需求进行定制。本文旨在探讨生物制剂的重要性、应用以及这种创新方法在医疗保健中的未来。首先，生物制剂最显著的优势之一是它们能够特异性地靶向体内某些途径。与可能影响多个系统的传统药物不同，生物制剂旨在与参与疾病过程的特定分子相互作用。例如，单克隆抗体作为一种生物制剂疗法，可以被设计成与癌细胞上的特定蛋白结合，从而抑制其生长。这种精确性不仅提高了治疗的有效性，还最小化了副作用，从而改善了患者的治疗效果。此外，生物制剂彻底改变了慢性疾病如类风湿关节炎、糖尿病和各种癌症的治疗。以前选择有限的患者现在受益于这些先进的疗法。例如，类风湿关节炎的生物制剂的引入改变了这种致残性疾病的管理，使许多人能够过上更加积极和充实的生活。与生物制剂相关的成功故事突显了它们改变现代医学格局的潜力。然而，生物制剂的开发和生产也带来了自身的一系列挑战。活生物体的复杂性意味着创建这些疗法通常是一个漫长且昂贵的过程。此外，生物制剂的制造需要严格的质量控制措施，以确保安全性和有效性。尽管面临这些障碍，但对研究和开发的投资仍在不断增长，这得益于生物制剂在治疗以前无法治疗的疾病方面的潜力。展望未来，生物制剂的前景似乎光明。生物技术的进步，包括基因编辑技术如CRISPR，为更具创新性的疗法铺平了道路。这些技术可能使得创造个性化的生物制剂成为可能，能够根据个体患者独特的基因组特征进行量身定制。这种发展可能彻底改变遗传疾病的治疗，并提高疗法的整体有效性。总之，生物制剂代表了医学领域的重要进展，为多种疾病提供了针对性和有效的治疗选择。随着研究的不断发展，生物制剂改善患者结果和改变医疗保健的潜力巨大。对理解和利用活生物体的持续承诺无疑将导致新的突破，增强我们对抗疾病的能力，提高无数个体的生活质量。随着我们迎接这一医学新时代，生物制剂的角色将继续扩大，塑造未来几代人的医疗保健。